Search

everythinglearnresearchcommunity

for

Search:↓

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Microneedling may help hair loss, but needs more research.

Adipose-derived stem cells show potential for skin rejuvenation and wound healing but require more research to overcome challenges and ensure safety.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

A man experienced life-threatening shock after swallowing hair growth solution.

Cyclosporin A promotes hair growth in mice and increases a protein linked to hair growth, but it may not work the same way in humans.

Zebrafish larvae are used to study and find treatments for ear cell damage because they are easier to observe and test than mammals.

Created tablet similar to Avodart using γ-cyclodextrin and solubilizers.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

The 2017 issue emphasized progress in laser and energy-based skin treatments, but noted the need for more research on certain procedures and technologies.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Latanoprost 0.1% may effectively treat hair loss.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Topical minoxidil is a safe and effective treatment for hair loss caused by androgenetic alopecia.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Potassium channel openers like minoxidil help hair grow by acting on hair follicles.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Sex hormones affect brain injury differently in males and females.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

About 15% of US Army personnel use hair products containing hormone or placenta, with higher usage among non-whites, females, and enlisted personnel.